Interpreting data first phase 3 for Terclara; Gaining an edge on the January 2025 phase 3 study.
My interpretation of the data
At this point I think I owe people a more thorough explanation of how I’m thinking about this trial, because in my piece on Moberg I didn’t have a great explanation presented to you, and it’s clear that most aren’t on the same page.
Knowing for certain what will happen is impossible. There are scenarios where this goes wrong. I’ll provide access to the primary documents in this post which are paywalled behind the typical academic paper data vendor bullshit (none of that money goes to funding research).